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1. Introduction 
In [ 1 ] we reported that bottromycin AZ has 
releasing action of peptidyl- or aminoacyl-tRNA 
from the acceptor site (A site) of ribosomes, but 
other reports on the action of bottromycin Az on the 
peptidyl transferase have been conflicting. It has been 
shown that bottromycin AZ does not interfere with 
the formation of polylysyl-puromycin [2], or with 
the puromycin reaction involving formylmethionyl- 
tRNA bound at the initiation site of ribosomes [3]. 
In contrast, it has been shown that N-acetyl phenyl- 
alanyl puromycin formation catalyzed by the pep- 
tidyltransferase was clearly inhibited by bottromycin 
AZ [4]. In view of these contradictory reports, we 
have attempted to relate the inhibitory effect of 
bottromycin AZ on peptide bond fo~ation to its 
action on peptidyl-t RNA at the A site of the ribo- 
somes. It was found that the inhibitory effect of 
bottromycin Az on the puromycin reaction can be 
understood on the basis of a change in the affinity of 
puromycin for the A site in the presence of bottro- 
mycin AZ_ Thus one can propose a hypothesis where- 
by bottromycin A2 acts by weakening the affinity of 
peptidyl or aminoacyl-tRNA and puromycin (analog 
of aminoacyl-tRNA) for the A site, This action results 
in the release of peptidyl-tRNA from the A site or in 
the inhibition of the puromycin reaction. 
2. Materials and methods 
2.1. Preparation of cell extracts from E. coli 
~scheri~hia coli Q13 (middle log) was purchased 
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from General Biochemical Co., ribosomes [S], run-off 
ribosomes [6], S-150 [6], EF G (elongation factor 
G) [S] and termination factor Ri [7] were prepared 
as described. Bottromycin A2 was a generous gift 
from Dr N. Tanaka of Tokyo University in Japan. 
2.2. Assa_v of polylysyl-puromycin forrnation 
For the formation of the ribosomal complex with 
poly [‘4C]lysyl-tRNA, the mixture (0.48 ml) con- 
tained 50 mM Tris-HCl (pH 7.8), 60 mM NH&l, 
18 mM Mg-acetate, 6 mM ~-mercapt~thanol, 0.2 mM 
GTP, 1 mM ATP, 7 mM phosphenolpyruvate, 60 yg 
pyruvate kinase, 105 ng tRNA mixture, 32 fig poIy(A), 
4 mg ribosomes,240ng S-150 and 0.4&i [14C]lysine. 
After incubating for 30 min at 37”C, the complex 
formed was isolated by sucrose density gradient cen- 
trifugation. The specific activity of the complex was 
1.2 X IO3 cpm/ff ,,. 
The mixture (0.2 ml) for the formation of poly- 
[i4C]lysyl-puromycin contained 50 mM Tris-HCl 
(pH 7.2), 100 mM NH,Cl, 13 mM Mg-acetate, 1 mM 
DTT (dlt~othreitol), 0.5 mM puromycin and I .65 
A260 units of the complex obtained above. Where 
indicated, 1 o-4 M bottromycin A*, 0.2 mM GTP and 
4.4 Erg elongation factor G were added. After incubat- 
ing for 15 min at 37”C, poly [ “C]lysyl-puromycin 
formed was measured as in [S] by following the 
decrease of the hot trichloroacetic acid-insoluble 
radioactivity. 
2.3. Preparation of the various ribosomal complexes 
with N-acetyl-( 14C/Phe-tRNA 
The ribosomal complex [l] having tRNAPhe and 
N-acetyl-[*4C]Phe-tRNAat thedonor~ite(DorPsite) 
and the A site, respectively, was prepared as in [9]. 
The ribosomal complex [ 111 having N-acetyl- [‘“Cl- 
Phe-tRNA at the D site was also prepared as in [9]. 
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2.4. Assay of the tern~i~l~t~oF1 reactiotz 
This was done essentially as in [7]. The reaction 
mixture (0.14 ml) contained 90 ~1 ribosomal complex 
of f-fr4C]Met-tRNA and AUG containing 3.2 X lo3 
cpm of f-[14C]~et-tRNA, 0.2 AZ60 unit of UAG and 
various volumes of termination factor Rr (127 pg/ml). 
Where indicated, lo-“ M bottromycin A, was added. 
incubation was carried out for 1 S min at 25°C. 
3. Results 
3.1. Inhibitory effect of bottromycin A2 on peptide 
bond formation 
The experiments indicated in table 1 show the 
effect of bottromycin Az on puromycin reaction 
involving ribosome-bound polylysyl-tRNA. In this 
experiment, the complex of polylysyl-tRNA, poly(A) 
and ribosomes was prepared in the reaction mixture 
for poly(A)-dependent polylysine formation. The 
complex was incubated with puromycin in the pres- 
ence or absence of bottromycin AZ. As can be seen 
from the upper llalf of this table, a significant inhibi- 
tion of polylysyl-puromycin formation was observed 
in the presence of bottromycin Aa. Some of the poly- 
lysyl-tRNA was apparently bound to the A site, 
because the addition of EFG and GTP increased the 
formation of polylysyl-puromycin. Even in the pres- 
ence of EFG and GTP, bottromycin Aa had a similar 
strong inhibitory effect. It should be pointed out that 
these experiments were performed under the identical 
conditions as the experiment in which no effect was 
observed [2]. It has been found that peptidyl- or 
aminoacyl-tRNA bound at the D site in the absence 
of EFG behaves differently from those peptidyl- or 
aminoacyl-tRNAs bound through the action of EFG 
[9]. It was therefore of interest to establish that 
bottromycin AZ can exert its effect on peptidyltrans- 
Table I 
Inhibitory effect ofbottromycin A, on polylysyl --puromycin 
formation 
__-__ --__ ~- 
Bottromycin A2 EFG Polylysyl-~puromycin 
(1 O-4 M) formed (cpm) 
- __~~__________ 
998 
+ _ 308 
_ + 1206 
+ + 326 
-_ -- _--- 
The experimental conditions were described in the text 
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Table 2 
Inhibitory effect of bottromycin A, on purumycin reactm 
with the substrate formed by the action of t:l% 
______ ~____.I.__.._ ____. ___.____._______--._ ~~ 
~ottromycin A, N-Acetyl-[ “C~l’henyialanyl 
(lo-” M) puromycm formed (cpm) 
___ _. _ _ 
5 min 10 mm 
._-- __-.._ _.“_ __._~ ~__ 
614 782 
t- 180 195 
-._-- .--. _____._ - “- ---__ ______-.-. ___II______ 
The mixture (A) (0.6 ml) for the translocation reaction con- 
tained 50 mM TrissHCl (pH 7.2), 50 mM NH,CI, 13 mM 
Mgacetate, 1 mM DTT, 4.65 A,,, units of the ribosomal 
complex [ 1) containing 1.22 X 1 O4 cpm of N-acetyl-[ 14C]- 
Phe-tRNA, 0.2 mM GTP and 17 clg EFG. It was incubated 
for 30 min at 37°C to complete the translocatron reaction. 
The mixture (0.2 ml) for the puromycin reaction contained 
0.5 mM puromycin and 17.5 pi of the incubated mixture. 
Where indicated, 10m4 M bottromycin A, was added. After 
incubating at 37”C, 80 ~1 reaction mixture were mixed with 
0.8 ml 10 mM Tris-Hfl (pH 7.8) and 2.5 ml ethylacetate. 
and after shaking vigorously, 2 ml ethylacetate layer were 
counted 
ferase activity with other aminoacyl- or peptidyi-tRNA 
which have been placed at D site under physiological 
conditions through the action of EFG. In the experi- 
ment indicated in table 2, the complex of N-acetyl- 
[14C]Phe-tRNA placed at the D site was prepared 
with EFG. Thus, the A site bound N-acetyl-[14C]- 
Phe-tRNA was treated with EFG and GTP so that is 
was physiologically placed at the D site. With this 
complex, the puromycin reaction with the ribosomal 
bound N-acetyl-[‘4C]Phe-tRNA was studied in the 
presence and absence of bottromycin A*. It is clear 
from this table that the strong inhibitory effect of 
bottromycin A* was observed with this complex also, 
indicating that bottromycin AZ can exert its inhibitory 
effect on peptidyltransferase activity with puromycin 
as an acceptor substrate. These results are consistent 
with [4] and establish that peptidyltransferase activ- 
ity involving N-acetyl- [r4C]Phe-t RNA and puromycin 
is indeed inhibited by bottromycin A*. 
It has been reported that bottromycin AZ couid 
not exert its inhibitory effect on the puromycin reac- 
tion with the nascent polypeptidyl-tRNA on poly- 
somes isolated from growing K. coii [IO]. It was 
therefore possible that inability of bottromycin AZ to 
inhibit the puromycin reaction with polysomes may 
be due to the possible presence of a factor(s) in these 
polysomes which has not gone through an extensive 
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Table 3 Table 4 
Inhibitory effect of bottromycin A, on the puromycin 
reaction with the run-off ribosomes 
Effect of increased amounts of puromycin on the inhibitory 
effect of bottromycin A, on peptidyltransferase activity 
~-- 
Bottromyc~n A, 
(lo-’ M) 
N-Acetyl-[ “C]Phenylalanyl- 
puromycin formed (cpm) 
_. 352 
+ 67 
Bottromycin A, Preincu- Puromy- N-Acetyl-fi4C]- 
(lo-“ M) bation tin (M) phenylalanyl- 
puromycin 
formed (cpm) 
The mixture (0.2 ml) for the puromycin reaction contained 
50 mM‘Tris-HCI (pH 7.2) 50 mM NH,CI, 6 mM Mg-acetate, 
1 mM DTT, 0.5 mM puromycin and 1 A,, unit of the ribo- 
somai complex [ 111 containing 700 cpm of N-acetyl-[“Y]- 
Phe4RNA. Where indicated, bottromycin A, was added to 
10m4 M. After incubating for 10 min at 37”C, the Nacetyl- 
[‘4C]Phenylalanyl-puromycin formed was measured with 
the ethylacetate xtraction technique 
washing procedure. It was therefore of interest to see 
if a similar peptidyltransferase reaction involving 
puromycin and ~-acetyl-[14C]Phe-tR~A is inhibited 
by bottromycin Az if one uses unwashed ribosomes 
isolated from naturally occurring polysomes. 
- _ 5 x lo-4 344 
+ __ 5~10-~ 86 
_ 3 x lo-’ 320 
+ _ 3 x lo-3 240 
- f 5 x lo-4 342 
+ + 5 x lo-4 8 
- + 3 x lo-J 360 
+ + 3x 10-3 44 
The mixture (0.2 ml) for the puromycin reaction was essen- 
tially the same as that of table 3 except that it contained 1.1 
A,,, unit of the ribosomal complex [ 111 containing 400 cpm 
N-acetyl-[ “C]Phe-tRNA. Where indicated, the ribosomal 
complex was preincubated with lo-’ M bottromy~in A, for 
2 min at 37°C. After incubating for 10 min at 37°C N-acetyl- 
[ “C]phenylalanyl-puromycin formed was measured by the 
ethylacetate xtraction method 
As shown in table 3, bottromycin A2 can exert its 
strong inhibitory effect on peptidyltransferase activ- 
ity with these unwashed ribosomes, suggesting that 
inability of bottromycin AZ to inhibit peptidyltrans- 
ferase activity involving polysomes is not due to the 
possible factor(s) associated with unwashed ribo- 
somes. The ribosomes used in these experiments are 
run-off ribosomes obtained from naturally occurring 
polysomes ]14]. 
3.2. Effect of various concentrations of puromycin 
on the inhibitory action ofbottromycin A2 on 
~epti~y~~aFlsferase activity 
In the experiment indicated in table 4, various 
concentrations of puromycin were used in the pep- 
tidyltransferase reaction assay involving the D-site- 
bound N-acetyl- [ r4C] Phe-t RNA. It is clear from this 
table that if puromycin concentration was increased, 
the inhibitory effect of bottromycin Aa was remark- 
ably reduced. However the inhibitory effect was 
almost complete regardless of the concentration of 
puromycin if the ribosomal complex was preincubated 
with bottromycin AZ prior to the addition of puro- 
mycin. 
polypeptide formation involves peptidyltransferase 
[ 121. One can visualize the termination reaction as 
the reaction of peptidyl-tRNA with water catalyzed 
by termination factor R,, Rz or RJ. Thus, the role of 
puromycin is played by water in this case. As shown 
in table 5, the termination reaction measured by the 
model complex having f-Met-tRNA at the D site and 
UAG at the A site was studied in the presence of 
various concentrations of Rr. As can be seen in table 
5, bottromycin Az appears to exert a strong inhibitory 
effect on the te~ination reaction and this inhibitory 
Table 5 
Jnhibitory effect of bottromycin A, on the termination 
reaction 
3.3. Inhibitory effect of bottromycin A 2 on the 
termination reaction 
It has been proposed that the termination step of 
Bottromycin A, Amounts of R, f-[ “C]Methionine 
(10-4) M used (~1) released (cpm) 
- 5 708 
+ 5 261 
- 10 1068 
+ 10 485 
.- 20 1402 
+ 20 616 
- 40 1462 
+ 40 805 
The experimental conditions were described in the text 
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effect cannot be appreciably overcome by the 
increased concentration of the termination factor, RI. 
This suggests that RI may bind to a part of the A site 
which is different from the site wherein puromycin 
or Hz0 interacts. 
4. Discussion 
The results reported in this letter establish that 
puromycin reaction can be inhibited by bottromycin 
AZ. The notion that bottromycin A2 uncouples the 
release of tRNA from the movement of peptidyl- 
tRNA from the acceptor site to the donor site [3] 
therefore is no longer valid because this notion was 
based on the premise that bottromycin A2 does not 
inhibit the puromycin reaction with polylysyl-tRNA 
[3]. The notion that EFG can release tRNA from the 
D site without movement of peptidyl-tRNA from the 
A site [3] is consequently not valid because this was 
based on the claim that bottromycin A2 uncouples 
the release of tRNA from the movement of peptidyl- 
tRNA. Our original proposal [ 131 that release of 
tRNA from the donor site during the translocation is 
a result of ‘push out’ by the movement of peptidyl- 
tRNA from the acceptor site to the donor site is there- 
fore still valid. EFG does not release tRNA at the 
donor site if another aminoacyl- or peptidyl-tRNA is 
not at the A site [13]. 
Having established that bottromycin A2 can inhibit 
the puromycin reaction with peptidyl-tRNA, this 
action ofbottromycin A2 must somehow be correlated 
with the other action of this antibiotic, namely, release 
of peptidyl-tRNA from the ribosomes. We propose 
the following hypothesis: 
Bottromycin A2 binds to the ribosome at or near 
the A site and weakens the affinity of the A site 
for peptidyl-tRNA, aminoacyl-tRNA and puro- 
mycin. The decreased affinity for the puromycin 
would result in decreased reaction with puromycin 
as described here. The influence of puromycin 
concentration on the bottromycin A2 effect sug- 
gests the binding site for this antibiotic is either at 
or very close to the A site. 
Thus, bottromycin represents another antibiotic, like 
tetracyline [ 151 which has a relatively specific action 
on the acceptor site of ribosomes. 
The lack of bottromycin A2 effect on diphenyl- 
alanine formation [ 111 also is consistent with the 
notion that the primary action of bottromycin is not 
to inhibit peptidyltransferase as such. If the Phe-tRNAs 
are situated on the D site and the A site of the ribo- 
some, peptide bond formation can take place in the 
presence of bottromycin A2 before Phe-tRNA is 
released from ribosomes by bottromycin. Thus, di- 
Phe-t RNA is made and is situated at the A site. This 
di-Phe-tRNA may in turn be released by bottromycin 
A2 from the ribosomes. 
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